- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Jessica Ringel
News 5 results
In the News · Source: Pharma Voice and Corporate Counsel
Recognition
September 19, 2024
King & Spalding Earns Multiple Rankings in LMG Life Sciences 2024 Guide
Cases & Deals
January 4, 2024
Acentra Health, a Carlyle Portfolio Company, Acquires Espyr
Recognition
September 21, 2023
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2023 Guide
Events 11 results
Webinar
February 24, 2026
Reading the Tea Leaves: Top 10 Enforcement and Regulatory Risks for Device Makers in 2026
Webinar
January 28, 2026
Drug & Device Advertising Year in Review: Lessons from 2025 FDA Enforcement & Key Developments
Conference
September 4, 2025
18th Annual King & Spalding Medical Device Summit
Insights 23 results
Client Alert
May 12, 2026
FDA’s New Oversight Tool: One-Day Inspectional Assessments
Client Alert
March 10, 2026
FDA Issues Draft Guidance on Responding to FDA Form 483 Observations Following Drug Inspections
Client Alert
February 3, 2026
The QMSR Goes Live and FDA Implements a New Medical Device Inspection Technique
Client Alert
January 21, 2026
2025 Year in Review: FDA Drug and Device Advertising and Promotion Enforcement